Skip to content

Spruce Biosciences, Inc.

SPRB

CIK 0001683553

← back to feed
Revenue (TTM)
$602K
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$36.59M
+26.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$50.97
+47.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-6,212.6%
Q1 May 2026
Net Margin
-6,077.4%
Q1 May 2026
Free Cash Flow (TTM)
−$48.21M
Q1 May 2026
Cash
$54.08M
Q1 May 2026
Total Debt
$6.46M
Q1 May 2026
Shares Outstanding
2.75M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings